{"filing":{"accession_number":"0001213900-26-072603","cik":"0001809616","ticker":"UPC","company_name":"Universe Pharmaceuticals INC","form":"6-K","filing_date":"2026-06-26","report_date":null,"primary_document":"ea0295794-6k_universe.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1809616/000121390026072603/ea0295794-6k_universe.htm"},"events":[{"id":14224,"run_id":12652,"accession_number":"0001213900-26-072603","anchor_item_number":"EX-99.1","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"summary":"Universe Pharmaceuticals announced entry into a share purchase agreement to acquire 100% of Best Praise International Limited for US$10.75 million in stock consideration (4,376,552 Class A ordinary shares). This is a material acquisition of a company holding five pharmaceutical patents. The transaction has been approved by the board and is expected to close in Q3 2026, representing a significant expansion of the Company's intellectual property portfolio and strategic direction.","company_name":"Universe Pharmaceuticals INC","ticker":"UPC","filing_date":"2026-06-26","form":"6-K","submitted_at":null,"items":[{"id":11592,"accession_number":"0001213900-26-072603","item_number":"EX-99.1","item_title":"ea029579401ex99-1.htm","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"Universe Pharmaceuticals announced entry into a share purchase agreement to acquire 100% of Best Praise International Limited for US$10.75 million in stock consideration (4,376,552 Class A ordinary shares). This is a material acquisition of a company holding five pharmaceutical patents. The transaction has been approved by the board and is expected to close in Q3 2026, representing a significant expansion of the Company's intellectual property portfolio and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-26T20:10:28.229920+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":11592,"accession_number":"0001213900-26-072603","item_number":"EX-99.1","item_title":"ea029579401ex99-1.htm","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"Universe Pharmaceuticals announced entry into a share purchase agreement to acquire 100% of Best Praise International Limited for US$10.75 million in stock consideration (4,376,552 Class A ordinary shares). This is a material acquisition of a company holding five pharmaceutical patents. The transaction has been approved by the board and is expected to close in Q3 2026, representing a significant expansion of the Company's intellectual property portfolio and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-26T20:10:28.229920+00:00","company_name":"Universe Pharmaceuticals INC","ticker":"UPC","filing_date":"2026-06-26"}]}